A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Study Identifier
191622-125
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Bladder Disorder - Overactive Bladder
  • Study Drug
  • BOTOX®
  • solifenacin
  • Botox placebo (normal saline)
  • solifenacin placebo
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    A study to evaluate the efficacy and safety of BOTOX® or Solifenacin in patients with overactive bladder (OAB) and urinary incontinence.

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable
    Location
    Leuven, Belgium
    Status
    Not applicable
    Location
    Vancouver, British Columbia, Canada
    Status
    Not applicable
    Location
    Toronto, Ontario, Canada
    Status
    Not applicable
    Location
    Prague, Czech Republic
    Status
    Not applicable
    Location
    Berlin, Germany
    Status
    Not applicable
    Showing {first} - {last} of {total} Results